Abstract
ABSTRACTIn December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.
Highlights
SHORT REVIEWRon5,*,‡, Philippe Sansonetti, Samantha Vanderslott and Lothar H
Infectious diseases continue to be a major factor in the development of health policy
The World Health Organization (WHO) was able to certify the eradication of smallpox in 1980, encouraging it and other non-governmental organisations to engage in a similar worldwide program to eradicate poliomyelitis
Summary
Ron5,*,‡, Philippe Sansonetti, Samantha Vanderslott and Lothar H. One sentence summary: Development of vaccines in the times of COVID-19.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
